Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis

BACKGROUND: Abacavir is a nucleoside reverse transcriptase inhibitor recommended in paediatric HIV care. We assessed the safety and efficacy profile of abacavir used in first, second, or subsequent lines of treatment for infants, children, and adolescents living with HIV to inform 2021 WHO paediatri...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesson, Julie, Saint-Lary, Laura, Revegue, Marc Harris Dassi Tchoupa, O’Rourke, John, Townsend, Claire L, Renaud, Françoise, Penazzato, Martina, Leroy, Valériane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474298/
https://www.ncbi.nlm.nih.gov/pubmed/36058225
http://dx.doi.org/10.1016/S2352-4642(22)00213-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474298/
https://www.ncbi.nlm.nih.gov/pubmed/36058225
http://dx.doi.org/10.1016/S2352-4642(22)00213-9

Ejemplares similares